| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 13.332 | 16.357 | 17.745 | 22.398 | 23.606 | 13.100 | 14.413 | 16.112 | 11.277 | 11.776 |
| Total Income - EUR | 13.332 | 16.357 | 17.745 | 22.398 | 23.606 | 13.105 | 14.413 | 16.112 | 11.277 | 11.776 |
| Total Expenses - EUR | 4.321 | 4.611 | 7.560 | 10.813 | 10.925 | 10.148 | 13.177 | 14.674 | 14.964 | 14.734 |
| Gross Profit/Loss - EUR | 9.011 | 11.745 | 10.185 | 11.586 | 12.681 | 2.957 | 1.236 | 1.438 | -3.687 | -2.958 |
| Net Profit/Loss - EUR | 8.611 | 11.255 | 9.750 | 11.362 | 12.445 | 2.832 | 1.092 | 1.277 | -3.799 | -3.312 |
| Employees | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Pediasan S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 789 | 502 | 224 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 2.003 | 10.401 | 10.443 | 21.998 | 18.220 | 3.522 | 4.764 | 3.390 | 778 | 1.874 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 74 | 1.436 | 230 | 258 | 0 | 0 | 0 | 0 | 0 | 201 |
| Cash | 1.929 | 8.965 | 10.213 | 21.740 | 18.220 | 3.522 | 4.764 | 3.390 | 778 | 1.673 |
| Shareholders Funds | -402 | 10.856 | 9.803 | 20.985 | 17.496 | 2.881 | 3.910 | 3.065 | -2.942 | -6.237 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.405 | 333 | 1.142 | 1.237 | 724 | 640 | 854 | 382 | 3.720 | 8.270 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Pediasan S.r.l.